BGP Product Operations

BGP Product Operations is a primary operational and manufacturing subsidiary of Viatris, a global healthcare company formed through the 2020 merger of Mylan and Pfizer's Upjohn division. The BGP entity was established following Mylan's 2015 acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business. It manages a vast portfolio of established medicines, including well-known brands like Creon, Influvac, and Lipanthyl, across diverse therapeutic areas such as gastroenterology, cardiology, and metabolic health. The company operates as a critical node in the Viatris global supply chain, overseeing complex manufacturing and distribution networks. Today, it supports Viatris's mission to provide high-quality, affordable medicines to patients in more than 165 countries and territories.